Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

Original Article

R.d. Wit, J.d. Bono, C.N. Sternberg, K. Fizazi, B. Tombal, C. Wülfing, G. Kramer, J.-C. Eymard, A. Bamias, J. Carles, R. Iacovelli, B. Melichar, Á. Sverrisdóttir, C. Theodore, S. Feyerabend, C. Helissey, A. Ozatilgan, C. Geffriaud-Ricouard, and D. Castellano

N Engl J Med 2019;381:2506-2518

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
12/25/2019
Course expires: 
12/26/2021

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Sunday, December 26, 2021 - 11:59pm.